30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Elanco Animal Health Inc (ELAN)

Track

In the last 90 days, Elanco Animal Health Inc. saw two insider buy transactions totaling $199,781.39. Notably, President and CEO Jeffrey N. Simmons and Rajeev A. Modi made purchases. This activity occurred after the company's last earnings report, which exceeded expectations by 17.65%. The stock has experienced a slight decline of 3.5% over the past 90 days.
Stock chart
Ticker: ELAN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Modi Rajeev A.
SEE REMARKS
1 purchase — total 99,939 USD
Buy 15 May 2026
Value US$2,925,858.76 | Price 469.83 | Shares 70,690
Buy 15 May 2026
Value US$65,709.89 | Price 197.05 | Shares 40,066
Buy 12 Dec 2025
Value US$213,000.00 | Price 21.30 | Shares 10,000
Buy 11 Dec 2025
Value US$150,426.50 | Price 21.64 | Shares 6,950
Planned buy 11 Dec 2025
Value US$95,985.00 | Price 21.33 | Shares 4,500
Buy 11 Dec 2025
Value US$478,495.60 | Price 21.75 | Shares 22,000
Proposed sale 11 Aug 2025
Value US$830,000.00 | Price 16.82 | Shares 49,333
Buy 11 Mar 2025
Value US$102,000.00 | Price 10.20 | Shares 10,000
Buy 7 Mar 2025
Value US$109,000.00 | Price 10.90 | Shares 10,000
Buy 5 Mar 2025
Value US$272,557.50 | Price 10.90 | Shares 25,000
Buy 22 Aug 2024
Value US$51,974.30 | Price 14.85 | Shares 3,500
Buy 12 Aug 2024
Value US$1,300,610.00 | Price 13.01 | Shares 100,000
Buy 21 May 2024
Value US$254,700.00 | Price 16.98 | Shares 15,000
Buy 8 Mar 2024
Value US$244,500.00 | Price 16.30 | Shares 15,000
Buy 8 Mar 2024
Value US$50,493.73 | Price 16.29 | Shares 3,100
Buy 6 Mar 2024
Value US$322,808.00 | Price 16.14 | Shares 20,000
Buy 14 Mar 2023
Value US$47,750.00 | Price 9.55 | Shares 5,000
Buy 13 Mar 2023
Value US$47,288.00 | Price 9.46 | Shares 5,000
Buy 10 Mar 2023
Value US$143,971.50 | Price 9.60 | Shares 15,000
Buy 3 Mar 2023
Value US$111,300.00 | Price 11.13 | Shares 10,000
Buy 11 Nov 2022
Value US$99,267.00 | Price 13.24 | Shares 7,500
Buy 9 Sep 2022
Value US$99,830.00 | Price 14.90 | Shares 6,700
Buy 9 Sep 2022
Value US$303,614.00 | Price 15.18 | Shares 20,000
Buy 9 Sep 2022
Value US$150,250.00 | Price 15.03 | Shares 10,000
Buy 9 Sep 2022
Value US$436,146.00 | Price 14.54 | Shares 30,000
Buy 20 May 2022
Value US$233,269.00 | Price 23.33 | Shares 10,000
Buy 11 May 2022
Value US$220,284.00 | Price 22.03 | Shares 10,000
Buy 2 Mar 2022
Value US$145,000.00 | Price 29.00 | Shares 5,000
Buy 1 Mar 2022
Value US$28,479.00 | Price 28.48 | Shares 1,000
Buy 1 Mar 2022
Value US$143,322.50 | Price 28.66 | Shares 5,000
Buy 30 Nov 2021
Value US$73,122.50 | Price 29.25 | Shares 2,500
Buy 30 Nov 2021
Value US$293,794.00 | Price 29.38 | Shares 10,000
Buy 15 Nov 2021
Value US$158,934.50 | Price 31.79 | Shares 5,000
Buy 11 May 2021
Value US$811,000.00 | Price 32.44 | Shares 25,000
Sale 3 Dec 2020
Value US$1,626,367,200.00 | Price 29.84 | Shares 54,500,000
Buy 28 Aug 2020
Value US$143,100.00 | Price 28.62 | Shares 5,000
Buy 27 Aug 2020
Value US$141,200.00 | Price 28.24 | Shares 5,000
Buy 21 Aug 2020
Value US$269,400.00 | Price 26.94 | Shares 10,000
Buy 19 Aug 2020
Value US$250,996.00 | Price 26.20 | Shares 9,580
Buy 6 Aug 2020
Value US$49,520.00 | Price 24.76 | Shares 2,000
Buy 3 Aug 2020
Value US$119,700.00 | Price 23.94 | Shares 5,000
Buy 3 Aug 2020
Value US$47,700.00 | Price 23.85 | Shares 2,000
Buy 13 Mar 2020
Value US$263,640.00 | Price 21.97 | Shares 12,000
Buy 9 Mar 2020
Value US$95,360.00 | Price 23.84 | Shares 4,000
Buy 6 Mar 2020
Value US$75,450.00 | Price 25.15 | Shares 3,000
Buy 4 Mar 2020
Value US$26,860.00 | Price 26.86 | Shares 1,000
Buy 2 Mar 2020
Value US$106,860.00 | Price 27.40 | Shares 3,900
Buy 28 Feb 2020
Value US$110,659.00 | Price 26.99 | Shares 4,100
Buy 22 Nov 2019
Value US$100,100.28 | Price 26.58 | Shares 3,766
Buy 18 Nov 2019
Value US$1,997.96 | Price 26.29 | Shares 76
Buy 18 Nov 2019
Value US$1,996.25 | Price 26.27 | Shares 76
Buy 18 Nov 2019
Value US$1,991.94 | Price 26.21 | Shares 76
Buy 11 Sep 2019
Value US$27,950.00 | Price 27.95 | Shares 1,000
Buy 4 Sep 2019
Value US$265,700.00 | Price 26.57 | Shares 10,000
Buy 4 Sep 2019
Value US$2,011,162.50 | Price 26.55 | Shares 75,750
Buy 22 Aug 2019
Value US$293,905.38 | Price 26.65 | Shares 11,030
Buy 22 Aug 2019
Value US$404,400.00 | Price 26.96 | Shares 15,000
Buy 13 May 2019
Value US$251,022.50 | Price 32.39 | Shares 7,750
Buy 22 Apr 2019
Value US$93,607.50 | Price 26.75 | Shares 3,500
Buy 13 Mar 2019
Value US$628,586.00 | Price 31.43 | Shares 20,000
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 7,977
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 1,227
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 37,301
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 2,021
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 1,227
Buy 11 Mar 2019
Value US$0.00 | Price 0.00 | Shares 920
Buy 24 Sep 2018
Value US$5,400.00 | Price 24.00 | Shares 225
Buy 24 Sep 2018
Value US$12,000.00 | Price 24.00 | Shares 500
Buy 24 Sep 2018
Value US$28,800.00 | Price 24.00 | Shares 1,200
Buy 24 Sep 2018
Value US$60,000.00 | Price 24.00 | Shares 2,500
Buy 24 Sep 2018
Value US$24,000.00 | Price 24.00 | Shares 1,000
Buy 24 Sep 2018
Value US$120,000.00 | Price 24.00 | Shares 5,000
Buy 24 Sep 2018
Value US$9,600.00 | Price 24.00 | Shares 400
Buy 24 Sep 2018
Value US$480,000.00 | Price 24.00 | Shares 20,000
Buy 24 Sep 2018
Value US$240,000.00 | Price 24.00 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-15 B Purchase
0.7
Modi Rajeev A.

SEE REMARKS

Officer
70,690 -10.7%
469.83
US$2,925,859 		70,690 -10.7% 469.83 US$2,925,859
2026-05-19 2026-05-15 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
40,066 +5.5%
197.05
US$65,710 		40,066 +5.5% 197.05 US$65,710
2025-12-16 2025-12-12 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
70,297 -2.2%
204.04
US$1,269,426 		70,297 -2.2% 204.04 US$1,269,426
2025-12-15 2025-12-11 B Purchase
2.5
VanHimbergen Robert M

EVP and CFO

Officer
6,950 +5.9%
21.64
US$150,426 		6,950 +5.9% 21.64 US$150,426
2025-12-15 2025-12-11 PP Planned purchase
0.7
Modi Rajeev A.

SEE REMARKS

Officer
4,500 +3.8%
21.33
US$95,985 		4,500 +3.8% 21.33 US$95,985
2025-12-15 2025-12-11 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
22,000 +15.2%
21.75
US$478,496 		22,000 +15.2% 21.75 US$478,496
2025-08-11 2025-08-11 PrS Proposed sale
3.6
Todd S and Jennifer G Young Living Trust Dtd 08/03/2021

Former CFO
49,333
16.82
US$830,000 		49,333 16.82 US$830,000
2025-03-11 2025-03-11 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +9.9%
10.20
US$102,000 		10,000 +9.9% 10.20 US$102,000
2025-03-11 2025-03-07 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +10.9%
10.90
US$109,000 		10,000 +10.9% 10.90 US$109,000
2025-03-07 2025-03-05 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
25,000 +13.5%
10.90
US$272,558 		25,000 +13.5% 10.90 US$272,558
2024-08-26 2024-08-22 B Purchase
2.4
Harrington Michael J
Non-Executive Director
3,500 +4.5%
14.85
US$51,974 		3,500 +4.5% 14.85 US$51,974
2024-08-13 2024-08-12 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
100,000 +222.2%
13.01
US$1,300,610 		100,000 +222.2% 13.01 US$1,300,610
2024-05-23 2024-05-21 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +24.5%
16.98
US$254,700 		15,000 +24.5% 16.98 US$254,700
2024-03-12 2024-03-08 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +32.4%
16.30
US$244,500 		15,000 +32.4% 16.30 US$244,500
2024-03-12 2024-03-08 B Purchase
2.4
Harrington Michael J
Non-Executive Director
3,100 +4.2%
16.29
US$50,494 		3,100 +4.2% 16.29 US$50,494
2024-03-08 2024-03-06 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +12.1%
16.14
US$322,808 		20,000 +12.1% 16.14 US$322,808
2023-03-15 2023-03-14 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.1%
9.55
US$47,750 		5,000 +3.1% 9.55 US$47,750
2023-03-15 2023-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.2%
9.46
US$47,288 		5,000 +3.2% 9.46 US$47,288
2023-03-13 2023-03-10 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
15,000 +50.0%
9.60
US$143,972 		15,000 +50.0% 9.60 US$143,972
2023-03-07 2023-03-03 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +6.9%
11.13
US$111,300 		10,000 +6.9% 11.13 US$111,300
2022-11-15 2022-11-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,500 +21.9%
13.24
US$99,267 		7,500 +21.9% 13.24 US$99,267
2022-09-09 2022-09-09 B Purchase
0.7
Modi Rajeev A.

SEE REMARKS

Officer
6,700 +19.4%
14.90
US$99,830 		6,700 +19.4% 14.90 US$99,830
2022-09-09 2022-09-09 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +16.0%
15.18
US$303,614 		20,000 +16.0% 15.18 US$303,614
2022-09-09 2022-09-09 B Purchase
0.7
Herendeen Paul
Non-Executive Director
10,000 +136.9%
15.03
US$150,250 		10,000 +136.9% 15.03 US$150,250
2022-09-09 2022-09-09 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
30,000 +inf%
14.54
US$436,146 		30,000 +inf% 14.54 US$436,146
2022-05-24 2022-05-20 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +8.7%
23.33
US$233,269 		10,000 +8.7% 23.33 US$233,269
2022-05-13 2022-05-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
10,000 +41.3%
22.03
US$220,284 		10,000 +41.3% 22.03 US$220,284
2022-03-02 2022-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.5%
29.00
US$145,000 		5,000 +4.5% 29.00 US$145,000
2022-03-03 2022-03-01 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +3.8%
28.48
US$28,479 		1,000 +3.8% 28.48 US$28,479
2022-03-02 2022-03-01 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.8%
28.66
US$143,322 		5,000 +4.8% 28.66 US$143,322
2021-12-02 2021-11-30 B Purchase
2.4
Harrington Michael J
Non-Executive Director
2,500 +9.7%
29.25
US$73,122 		2,500 +9.7% 29.25 US$73,122
2021-12-02 2021-11-30 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +10.5%
29.38
US$293,794 		10,000 +10.5% 29.38 US$293,794
2021-11-17 2021-11-15 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +5.6%
31.79
US$158,934 		5,000 +5.6% 31.79 US$158,934
2021-05-12 2021-05-11 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
25,000 +55.6%
32.44
US$811,000 		25,000 +55.6% 32.44 US$811,000
2020-12-03 2020-12-03 S Sale
1.6
BAYER AKTIENGESELLSCHAFT
Large shareholder
54,500,000 -74.7%
29.84
US$1,626,367,200 		54,500,000 -74.7% 29.84 US$1,626,367,200
2020-08-28 2020-08-28 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +12.5%
28.62
US$143,100 		5,000 +12.5% 28.62 US$143,100
2020-08-28 2020-08-27 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +16.1%
28.24
US$141,200 		5,000 +16.1% 28.24 US$141,200
2020-08-24 2020-08-21 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
10,000 +47.4%
26.94
US$269,400 		10,000 +47.4% 26.94 US$269,400
2020-08-19 2020-08-19 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
9,580 +65.4%
26.20
US$250,996 		9,580 +65.4% 26.20 US$250,996
2020-08-07 2020-08-06 B Purchase
3.4
GARCIA ART A
Non-Executive Director
2,000 +28.3%
24.76
US$49,520 		2,000 +28.3% 24.76 US$49,520
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
5,000 +inf%
23.94
US$119,700 		5,000 +inf% 23.94 US$119,700
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
2,000 +inf%
23.85
US$47,700 		2,000 +inf% 23.85 US$47,700
2020-03-16 2020-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
12,000 +42.9%
21.97
US$263,640 		12,000 +42.9% 21.97 US$263,640
2020-03-11 2020-03-09 B Purchase
2.4
Harrington Michael J
Non-Executive Director
4,000 +31.3%
23.84
US$95,360 		4,000 +31.3% 23.84 US$95,360
2020-03-06 2020-03-06 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
3,000 +25.8%
25.15
US$75,450 		3,000 +25.8% 25.15 US$75,450
2020-03-06 2020-03-04 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +8.1%
26.86
US$26,860 		1,000 +8.1% 26.86 US$26,860
2020-03-03 2020-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
3,900 +16.2%
27.40
US$106,860 		3,900 +16.2% 27.40 US$106,860
2020-03-03 2020-02-28 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
4,100 +20.5%
26.99
US$110,659 		4,100 +20.5% 26.99 US$110,659
2019-11-25 2019-11-22 B Purchase BILBREY JOHN P Non-Executive Director
3,766 +47.8%
26.58
US$100,100 		3,766 +47.8% 26.58 US$100,100
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.29
US$1,998 		76 +inf% 26.29 US$1,998
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.27
US$1,996 		76 +inf% 26.27 US$1,996
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.21
US$1,992 		76 +inf% 26.21 US$1,992
2019-09-12 2019-09-11 B Purchase
2.0
Kochevar Deborah Turner
1,000 +35.9%
27.95
US$27,950 		1,000 +35.9% 27.95 US$27,950
2019-09-05 2019-09-04 B Purchase
3.6
YOUNG TODD S.

See Remarks
10,000 +53.0%
26.57
US$265,700 		10,000 +53.0% 26.57 US$265,700
2019-09-05 2019-09-04 B Purchase
3.4
Simmons Jeffrey N

President, CEO & Director

Executive Director
75,750 +19.2%
26.55
US$2,011,162 		75,750 +19.2% 26.55 US$2,011,162
2019-08-26 2019-08-22 B Purchase Hicks Michael-Bryant

See Remarks

Officer
11,030 +48.2%
26.65
US$293,905 		11,030 +48.2% 26.65 US$293,905
2019-08-26 2019-08-22 B Purchase HOOVER R DAVID Non-Executive Director
15,000 +1630.4%
26.96
US$404,400 		15,000 +1630.4% 26.96 US$404,400
2019-05-15 2019-05-13 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,750 +inf%
32.39
US$251,022 		7,750 +inf% 32.39 US$251,022
2019-08-26 2019-04-22 B Purchase Harrington Michael J Non-Executive Director
3,500 +125.8%
26.75
US$93,608 		3,500 +125.8% 26.75 US$93,608
2019-03-14 2019-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +inf%
31.43
US$628,586 		20,000 +inf% 31.43 US$628,586
2019-03-13 2019-03-11 B Purchase
Kinard David S

See Remarks

Officer
7,977
0.00
US$0 		7,977 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Schacht Aaron L

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
3.4
Simmons Jeffrey N

Presiident, CEO & Director

Executive Director
37,301
0.00
US$0 		37,301 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.3
Urbanek David Alan

See Remarks

Officer
2,021
0.00
US$0 		2,021 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Cabral Ramiro Martin

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
920
0.00
US$0 		920 0.00 US$0
2018-09-26 2018-09-24 B Purchase Meer James M

Chief Accounting Officer
225 +inf%
24.00
US$5,400 		225 +inf% 24.00 US$5,400
2018-09-26 2018-09-24 B Purchase Urbanek David Alan

See Remarks
500 +inf%
24.00
US$12,000 		500 +inf% 24.00 US$12,000
2018-09-26 2018-09-24 B Purchase Anand Kapila K
1,200 +inf%
24.00
US$28,800 		1,200 +inf% 24.00 US$28,800
2018-09-26 2018-09-24 B Purchase Kinard David S

See Remarks
2,500 +inf%
24.00
US$60,000 		2,500 +inf% 24.00 US$60,000
2018-09-26 2018-09-24 B Purchase Cabral Ramiro Martin

See Remarks
1,000 +inf%
24.00
US$24,000 		1,000 +inf% 24.00 US$24,000
2018-09-26 2018-09-24 B Purchase Hicks Michael-Bryant

See Remarks
5,000 +inf%
24.00
US$120,000 		5,000 +inf% 24.00 US$120,000
2018-09-26 2018-09-24 B Purchase Schacht Aaron L

See Remarks
400 +inf%
24.00
US$9,600 		400 +inf% 24.00 US$9,600
2018-09-26 2018-09-24 B Purchase LIN SARENA S

See Remarks
20,000 +inf%
24.00
US$480,000 		20,000 +inf% 24.00 US$480,000
2018-09-26 2018-09-24 B Purchase Kurzius Lawrence Erik
10,000 +inf%
24.00
US$240,000 		10,000 +inf% 24.00 US$240,000
Explore more

More insider trading research around Elanco Animal Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America